Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

Yujeong Kim, Hye Young Kwon*, Brian Godman, Evelien Moorkens, Steven Simoens, Seung Jin Bae*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?'. Together they form a unique fingerprint.

Keyphrases

Agricultural and Biological Sciences